Pharmaceutics & Novel Drug Delivery Systems

Inhalation Drug Delivery: Novel Approaches and Device Technologies

Inhalation drug delivery has gained significant importance as a targeted and effective route for delivering drugs to the respiratory system. This session will focus on the novel approaches and device technologies in inhalation drug delivery, exploring advancements in this field. Inhalation drug delivery offers several advantages, including rapid onset of action, direct targeting of the lungs, and avoidance of first-pass metabolism. The session will delve into innovative inhalation formulations, such as dry powder inhalers (DPIs), metered-dose inhalers (MDIs), and nebulizers, as well as advancements in device technologies. Attendees will gain insights into the design and development of inhalation devices, including considerations for optimizing drug delivery, ease of use, and patient compliance. Discussions will cover topics such as aerosol generation, particle size optimization, and improvements in inhaler design. The session will also highlight the application of inhalation drug delivery in various therapeutic areas, such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections. The ability to deliver medications directly to the site of action in the respiratory system holds great promise for improving treatment outcomes. Furthermore, discussions will address the challenges associated with inhalation drug delivery, including patient variability, device misuse, and regulatory considerations.

Overall, this session on inhalation drug delivery will showcase the latest advancements and explore the potential of novel approaches and device technologies. It will serve as a platform for researchers, clinicians, and industry professionals to exchange knowledge, foster collaborations, and shape the future of inhalation drug delivery.